Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use
✍ Scribed by William R. Carpenter; Paul A. Godley; Jack A. Clark; James A. Talcott; Timothy Finnegan; Merle Mishel; Jeannette Bensen; Walter Rayford; L. Joseph Su; Elizabeth T. H. Fontham; James L. Mohler
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 157 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND:
Nonmedical factors may modify the biological risk of prostate cancer (PCa) and contribute to the differential use of early detection; curative care; and, ultimately, greater racial disparities in PCa mortality. In this study, the authors examined patients' usual source of care, continuity of care, and mistrust of physicians and their association with racial differences in PCa screening.
METHODS:
Study nurses conducted in‐home interviews of 1031 African‐American men and Caucasian‐American men aged ≥50 years in North Carolina and Louisiana within weeks of their PCa diagnosis. Medical records were abstracted, and the data were used to conduct bivariate and multivariate analyses.
RESULTS:
Compared with African Americans, Caucasian Americans exhibited higher physician trust scores and a greater likelihood of reporting a physician office as their usual source of care, seeing the same physician at regular medical encounters, and historically using any PCa screening. Seeing the same physician for regular care was associated with greater trust and screening use. Men who reported their usual source of care as a physician office, hospital clinic, or Veterans Administration facility were more likely to report prior PCa screening than other men. In multivariate regression analysis, seeing the same provider remained associated with prior screening use, whereas both race and trust lost their association with prior screening.
CONCLUSIONS:
The current results indicated that systems factors, including those that differ among different sources of care and those associated with the continuity of care, may provide tangible targets to address disparities in the use of PCa early detection, may attenuate racial differences in PCa screening use, and may contribute to reduced racial disparities in PCa mortality. Cancer 2009. Published 2009 by the American Cancer Society.
📜 SIMILAR VOLUMES
## Abstract Safety concerns surrounding the use of recombinant human erythropoietin (Epo) to treat anemia in cancer patients were raised after 2 recent clinical studies reported a worse survival outcome in patients who received epoetin α or epoetin β compared with patients who received placebo. Alt
## Abstract __Background__: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utility‐based preferences for alternative CRC screening tests from a stated‐preference discrete‐choice survey of the general population and physicians in Canada and the United States.